eTable 1. Medical morbidity and risk factors in patients with and without borderline personality disorder, psychotic disorders, bipolar disorder, or severe unipolar depression (complete data; administrative data of all statutory health insured adults in Germany, age ≥ 18 years*1, 2016).
Borderline personality disorder | Psychotic disorders | Bipolar disorder | Severe unipolar depression | ||||||
Medical morbidity / risk factor (base rate, i.e., prevalence in whole population) | ICD-10 code | OR*2 | (95% CI) | OR*2 | (95% CI) | OR*2 | (95% CI) | OR | 95-%-KI |
Hepatitis, human immunodeficiency virus (0.675%) | B15–B24 | 4.28 | [4.15; 4.40] | 2.39 | [2.35; 2.44] | 1.91 | [1.84; 1.99] | 2.08 | [2.05; 2.12] |
Malignant neoplasms (MN) (8.062%) | C00–C97 | 1.11 | [1.09; 1.14] | 0.90 | [0.89; 0.90] | 1.07 | [1.06; 1.09] | 1.30 | [1.29; 1.31] |
MN of lip, oral cavity, and pharynx (0.153%) | C00–C14 | 1.33 | [1.15; 1.53] | 0.98 | [0.92; 1.03] | 0.97 | [0.89; 1.12] | 1.36 | [1.31; 1.42] |
MN of digestive organs (1.051%) | C15–C26 | 1.25 | [1.17; 1.33] | 0.92 | [0.90; 0.94] | 1.01 | [0.97; 1.05] | 1.25 | [1.23; 1.27] |
MN of respiratory and other intrathoracic organs (0.376%) | C30–C39 | 1.29 | [1.17; 1.43] | 1.05 | [1.01; 1.09] | 1.00 | [0.93; 1.08] | 1.45 | [1.42; 1.48] |
MN of bronchus and lung (0.288%) | C34 | 1.32 | [1.18; 1.48] | 1.07 | [1.03; 1.11] | 0.99 | [0.91; 1.07] | 1.46 | [1.42; 1.50] |
MN of bone and articular cartilage (0.040%) | C40–C41 | 1.32 | [1.07; 1.64] | 1.06 | [0.95; 1.18] | 1.36 | [1.12; 1.65] | 1.56 | [1.45; 1.67] |
Melanoma and other MN of skin (2.455%) | C43–C44 | 0.91 | [0.87; 0.96] | 0.76 | [0.75; 0.77] | 0.99 | [0.97; 1.02] | 1.08 | [1.07; 1.09] |
MN of mesothelial and soft tissue (0.107%) | C45–C49 | 1.28 | [1.09; 1.50] | 0.96 | [0.90; 1.03] | 1.15 | [1.01; 1.30] | 1.53 | [1.47; 1.60] |
MN of breast (1.493%) | C50 | 0.10 | [0.93; 1.02] | 1.00 | [0.99; 1.02] | 1.15 | [1.12; 1.19] | 1.36 | [1.35; 1.38] |
MN of female genital organs (0.482%) | C51–C58 | 1.70 | [1.61; 1.80] | 1.08 | [1.05; 1.11] | 1.13 | [1.06; 1.19] | 1.34 | [1.32; 1.37] |
MN of male genital organs (1.190%) | C60–C63 | 0.98 | [0.90; 1.05] | 0.77 | [0.75; 0.79] | 1.09 | [1.04; 1.14] | 1.37 | [1.35; 1.39] |
MN of prostate (1.080%) | C61 | 0.93 | [0.85; 1.02] | 0.74 | [0.72; 0.76] | 1.06 | [1.01; 1.11] | 1.36 | [1.33; 1.38] |
MN of urinary tract (0.682%) | C64–C68 | 1.16 | [1.07; 1.27] | 0.90 | [0.88; 0.93] | 1.01 | [0.96; 1.07] | 1.33 | [1.30; 1.35] |
MN of eye. brain, other CNS sites (0.114%) | C69–C72 | 1.42 | [1.25; 1.61] | 1.28 | [1.21; 1.36] | 1.27 | [1.13; 1.43] | 1.79 | [1.72; 1.86] |
MN of thyroid and other endocrine glands (0.175%) | C73–C75 | 1.12 | [1.00; 1.25] | 0.95 | [0.90; 1.00] | 1.35 | [1.24; 1.48] | 1.47 | [1.43; 1.52] |
MN of ill-defined, secondary, and unspecific sites (1.075%) | C76–C80 | 1.22 | [1.16; 1.30] | 0.96 | [0.94; 0.98] | 1.07 | [1.02; 1.11] | 1.42 | [1.40; 1.44) |
MN (primary) of lymphoid, hematopoietic, and related tissues (0.657%) | C81–C96 | 1.17 | [1.09; 1.25] | 0.92 | [0.89; 0.94] | 1.04 | [0.99; 1.10] | 1.33 | [1.31; 1.36] |
Hodgkin lymphoma (0.078%) | C81 | 1.08 | [0.92; 1.27] | 1.04 | [0.96; 1.12] | 1.10 | [0.94; 1.29] | 1.51 | [1.43; 1.59] |
MN as primary tumors at several sites (0.012%) | C97 | 1.35 | [0.78; 2.33] | 0.94 | [0.77; 1.15] | 1.31 | [0.92; 1.88] | 1.65 | [1.46; 1.87] |
Endocrine, nutritional and metabolic ‧diseases (48.590%) | E00–E90 | 1.70 | [1.69; 1.72] | 1.42 | [1.42; 1.43] | 1.61 | [1.59; 1.63] | 1.75 | [1.74; 1.76] |
Diabetes mellitus (12.801%) | E10–E14 | 1.85 | [1.82; 1.88] | 1.61 | [1.60; 1.62] | 1.27 | [1.25; 1.28] | 1.41 | [1.40; 1.41] |
Obesity (12.442%) | E66 | 2.08 | [2.06; 2.10] | 1.60 | [1.59; 1.61] | 1.45 | [1.43; 1.47] | 1.53 | [1.53; 1.54] |
Disorders of lipoprotein metabolism and other lipidemias (22.891%) | E78 | 1.34 | [1.32; 1.36] | 0.99 | [0.99; 1.00] | 1.13 | [1.11; 1.14] | 1.37 | [1.37; 1.38] |
Organic mental disorders and dementias (4.063%) | F0, G30–G31 | 4.60 | [4.50; 4.71] | 8.43 | [8.37; 8.49] | 3.85 | [3.79; 3.92] | 3.09 | [3.07; 3.11] |
Mental and behavioral disorders due to alcohol (2.239%) | F10 | 12.23 | [12.06; 12.40] | 4.25 | [4.22; 4.29] | 4.10 | [4.03; 4.17] | 3.18 | [3.15; 3.20] |
Mental and behavioral disorders due to psychotropic substances (except alcohol) (6.937%) | F11–F19 | 5.28 | [5.22; 5.33] | 3.02 | [3.00; 3.03] | 2.27 | [2.24; 2.30] | 2.18 | [2.17; 2.20] |
Diseases of the circulatory system (47.391%) | I00–I99 | 1.50 | [1.49; 1.52] | 1.15 | [1.14; 1.16] | 1.26 | [1.25; 1.28] | 1.63 | [1.62; 1.63] |
Hypertension (35.640%) | I10–I15 | 1.40 | [1.39; 1.42] | 1.01 | [1.00; 1.02] | 1.12 | [1.11; 1.14] | 1.42 | [1.42; 1.43] |
Ischemic heart disease (8.841%) | I20–I25 | 1.60 | [1.56; 1.64] | 1.02 | [1.02; 1.03] | 1.13 | [1.11; 1.15] | 1.53 | [1.52; 1.54] |
Cardiac arrhythmia (9.722%) | I44–I49 | 1.46 | [1.43; 1.49] | 0.97 | [0.96; 0.97] | 1.11 | [1.09; 1.13] | 1.33 | [1.32; 1.33] |
Atrial fibrillation (4.246%) | I48 | 1.18 | [1.13; 1.22] | 0.93 | [0.92; 0.94] | 0.98 | [0.96; 1.00] | 1.15 | [1.14; 1.16] |
Heart failure (4.783%) | I50 | 1.82 | [1.77; 1.88] | 1.48 | [1.47; 1.49] | 1.32 | [1.29; 1.34] | 1.53 | [1.52; 1.55] |
Cerebrovascular disease (6.365%) | I60–I69 | 1.79 | [1.74; 1.83] | 1.39 | [1.38; 1.40] | 1.47 | [1.44; 1.49] | 1.76 | [1.75; 1.77] |
Diseases of the arteries, arterioles, capillaries (7.230%) | I70–I79 | 1.66 | [1.63; 1.70] | 1.01 | [1.00; 1.02] | 1.15 | [1.14; 1.17] | 1.41 | [1.40; 1.42] |
Respiratory system diseases (46.156%) | J00–J99 | 1.41 | [1.40; 1.42] | 0.96 | [0.96; 0.97] | 1.16 | [1.15; 1.17] | 1.43 | [1.42; 1.43] |
Pneumonia (1.008%) | J12–J18 | 1.74 | [1.67; 1.81] | 1.71 | [1.68; 1.74] | 1.55 | [1.49; 1.61] | 1.67 | [1.64; 1.67] |
Chronic obstructive pulmonary disease (6.060%) | J43–J44 | 2.60 | [2.55; 2.64] | 1.58 | [1.57; 1.59] | 1.43 | [1.41; 1.46] | 1.79 | [1.78; 1.80] |
Asthma (7.549%) | J45–J46 | 2.12 | [2.09; 2.14] | 1.07 | [1.06; 1.08] | 1.31 | [1.29; 1.33] | 1.60 | [1.59; 1.61] |
Injuries, poisonings, other consequences of external causes (28.229%) | S00–T98 | 1.96 | [1.94; 1.97] | 1.19 | [1.18; 1.19] | 1.38 | [1.37; 1.40] | 1.49 | [1.48; 1.49] |
External causes of morbidity and mortality (0.297%) | V01–Y98 | 4.29 | [4.12; 4.46] | 1.81 | [1.76; 1.87] | 1.85 | [1.73; 1.97] | 1.88 | [1.84; 1.93] |
Accidents (0.161%) | V01–X59 | 2.20 | [2.05; 2.36] | 1.26 | [1.20; 1.33] | 1.49 | [1.35; 1.64] | 1.41 | [1.35; 1.46] |
Intentional self-harm (0.011%) | X60–X84 | 56.22 | [52.76; 59.90] | 18.81 | [17.57; 20.15] | 11.10 | [9.53; 12.93] | 15.73 | [14.73; 16.68] |
All odds ratios (OR) are shown, irrespective of significance or effect size; in the case of a lower/upper CI limits of <1 or >1 respectively, the result is statistically significant (p <0.05; in most cases
p < 0.01); effects that are both significant and rated as substantial (OR >1.436 or OR <0.696) are in bold type.
Results are adjusted for age and sex.
*1 Data from statutory health insurance funds; 2016: N = 59 561 310 (not included: adults in Germany with private [10.5%] and no [ca. 2%] health insurance); mean age = 51.25 years, % female 55.40; ICD-10 diagnoses included: F60.3x, F2x, F30.x/F31.x, F32.2/F33.2/F33.2/F33.3
*2 OR with 95% CI; adjusted for age and sex; reference groups: respective diagnosis not present